BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31710026)

  • 1. Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells.
    Good ML; Vizcardo R; Maeda T; Tamaoki N; Malekzadeh P; Kawamoto H; Restifo NP
    J Vis Exp; 2019 Oct; (152):. PubMed ID: 31710026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation.
    Nishimura T; Kaneko S; Kawana-Tachikawa A; Tajima Y; Goto H; Zhu D; Nakayama-Hosoya K; Iriguchi S; Uemura Y; Shimizu T; Takayama N; Yamada D; Nishimura K; Ohtaka M; Watanabe N; Takahashi S; Iwamoto A; Koseki H; Nakanishi M; Eto K; Nakauchi H
    Cell Stem Cell; 2013 Jan; 12(1):114-26. PubMed ID: 23290140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Generation of iPSC-Derived Hematoendothelial Progenitors and Specification Toward T cell Lineage.
    Suwanpitak S; Promnakhon N; Netsrithong R; Wattanapanitch M
    Methods Mol Biol; 2022; 2454():423-442. PubMed ID: 33755900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of highly proliferative, rejuvenated cytotoxic T cell clones through pluripotency reprogramming for adoptive immunotherapy.
    Kawai Y; Kawana-Tachikawa A; Kitayama S; Ueda T; Miki S; Watanabe A; Kaneko S
    Mol Ther; 2021 Oct; 29(10):3027-3041. PubMed ID: 34023508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of Tumor Antigen-Specific iPSC-Derived Thymic Emigrants Using a 3D Thymic Culture System.
    Vizcardo R; Klemen ND; Islam SMR; Gurusamy D; Tamaoki N; Yamada D; Koseki H; Kidder BL; Yu Z; Jia L; Henning AN; Good ML; Bosch-Marce M; Maeda T; Liu C; Abdullaev Z; Pack S; Palmer DC; Stroncek DF; Ito F; Flomerfelt FA; Kruhlak MJ; Restifo NP
    Cell Rep; 2018 Mar; 22(12):3175-3190. PubMed ID: 29562175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of BCMA-specific induced pluripotent stem cells into rejuvenated CD8αβ+ T cells targeting multiple myeloma.
    Bae J; Kitayama S; Herbert Z; Daheron L; Kurata K; Keskin DB; Livak K; Li S; Tarannum M; Romee R; Samur M; Munshi NC; Kaneko S; Ritz J; Anderson KC
    Blood; 2024 Mar; 143(10):895-911. PubMed ID: 37890146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy.
    Minagawa A; Yoshikawa T; Yasukawa M; Hotta A; Kunitomo M; Iriguchi S; Takiguchi M; Kassai Y; Imai E; Yasui Y; Kawai Y; Zhang R; Uemura Y; Miyoshi H; Nakanishi M; Watanabe A; Hayashi A; Kawana K; Fujii T; Nakatsura T; Kaneko S
    Cell Stem Cell; 2018 Dec; 23(6):850-858.e4. PubMed ID: 30449714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive Transfer of CD8+ T Cells Generated from Induced Pluripotent Stem Cells Triggers Regressions of Large Tumors Along with Immunological Memory.
    Saito H; Okita K; Chang AE; Ito F
    Cancer Res; 2016 Jun; 76(12):3473-83. PubMed ID: 27197199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced Pluripotent Stem Cell-Derived T Cells for Cancer Immunotherapy.
    Patel SJ; Yamauchi T; Ito F
    Surg Oncol Clin N Am; 2019 Jul; 28(3):489-504. PubMed ID: 31079802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants.
    Vizcardo R; Rafiqul Islam SM; Maeda T; Tamaoki N; Good ML; Klemen ND; Bosch-Marce M; Jia L; Kruhlak MJ; Restifo NP
    J Vis Exp; 2019 Aug; (150):. PubMed ID: 31449236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of Antigen-Specific T Cells from Human Induced Pluripotent Stem Cells.
    Nishimura T; Nakauchi H
    Methods Mol Biol; 2019; 1899():25-40. PubMed ID: 30649763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells.
    van der Stegen SJC; Lindenbergh PL; Petrovic RM; Xie H; Diop MP; Alexeeva V; Shi Y; Mansilla-Soto J; Hamieh M; Eyquem J; Cabriolu A; Wang X; Abujarour R; Lee T; Clarke R; Valamehr B; Themeli M; Riviere I; Sadelain M
    Nat Biomed Eng; 2022 Nov; 6(11):1284-1297. PubMed ID: 35941192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming away from the exhausted T cell state.
    Karagiannis P; Iriguchi S; Kaneko S
    Semin Immunol; 2016 Feb; 28(1):35-44. PubMed ID: 26589493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Generation of Human γδT Cell-Derived Induced Pluripotent Stem Cells from Whole Peripheral Blood Mononuclear Cell Culture.
    Watanabe D; Koyanagi-Aoi M; Taniguchi-Ikeda M; Yoshida Y; Azuma T; Aoi T
    Stem Cells Transl Med; 2018 Jan; 7(1):34-44. PubMed ID: 29164800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purging Exhausted Virus-Specific CD8 T Cell Phenotypes by Somatic Cell Reprogramming.
    Chan J; Kim PY; Kranz E; Nagaoka Y; Lee Y; Wen J; Elsaesser HJ; Qin M; Brooks DG; Ringpis GE; Chen ISY; Kamata M
    AIDS Res Hum Retroviruses; 2017 Nov; 33(S1):S59-S69. PubMed ID: 29140111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes.
    Saito H; Iwabuchi K; Fusaki N; Ito F
    J Vis Exp; 2016 Nov; (117):. PubMed ID: 27911363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pluripotent stem cells as a source for T cell research and clinical application].
    Ueda T; Kaneko S
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(2):101-8. PubMed ID: 26016637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regeneration of CD8αβ T Cells from T-cell-Derived iPSC Imparts Potent Tumor Antigen-Specific Cytotoxicity.
    Maeda T; Nagano S; Ichise H; Kataoka K; Yamada D; Ogawa S; Koseki H; Kitawaki T; Kadowaki N; Takaori-Kondo A; Masuda K; Kawamoto H
    Cancer Res; 2016 Dec; 76(23):6839-6850. PubMed ID: 27872100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
    Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
    Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redifferentiation of Adaptive Naïve-Like CTL from T-Cell-Derived iPSC.
    Kawai Y; Kaneko S
    Methods Mol Biol; 2019; 2048():71-75. PubMed ID: 31396930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.